Delivery Order SPE2DB22D2206-SPE2DB24FFT48
Award Date 2/23/24
Potential Completion Date 2/26/24
Potential Value $3.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,914.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 30 mg kits. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 and in effect through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract, valued at $2,648.30, to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Sandostatin LAR Depot 20 mg kits. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,389,740 units of Sandostatin LAR Depot 20 mg pharmaceutical kits. The $9,741.90 firm fixed price contract has an ultimate completion date of April 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,648.30 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of Sandostatin LAR Depot, a specialty pharmaceutical product, with a completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,093.99 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 10 mg pharmaceutical kits. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of the pharmaceutical product Sandostatin LAR Depot 30 mg kits. The contract has a firm fixed-price of $31,925.12 and an ultimate completion date of July 10, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 20 mg kits, valued at $16,818.24, with a completion date of December 9, 2025. This non-set-aside award was made competitively and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- This delivery order award, valued at $27,818.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg Kits. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen, as a major pharmaceutical distributor, holds multiple indefinite delivery contracts (IDCs) with DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SANDOSTATIN LAR DEPOT 30 MG KTS pharmaceutical products. This $3,914.52 contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical and medical supplies to government agencies, particularly the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $7,829.04 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of Sandostatin LAR Depot 30 MG KTS, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFT48Delivery Order
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $3,914.52 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for Sandostatin LAR Depot 30 mg medication kits, with a completion date of February 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to military treatment facilities worldwide. This delivery order was issued under that IDC and does not have a set-aside designation.
Generated 5/24/24, 10:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 2/23/24 |